In last trading session, Apogee Therapeutics Inc (NASDAQ:APGE) saw 0.67 million shares changing hands with its beta currently measuring 1.46. Company’s recent per share price level of $39.94 trading at $1.61 or 4.20% at ring of the bell on the day assigns it a market valuation of $2.38B. That closing price of APGE’s stock is at a discount of -79.64% from its 52-week high price of $71.75 and is indicating a premium of 27.14% from its 52-week low price of $29.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.91 million shares which gives us an average trading volume of 575.10K if we extend that period to 3-months.
Apogee Therapeutics Inc (NASDAQ:APGE) trade information
Upright in the green during last session for gaining 4.20%, in the last five days APGE remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $39.94 price level, adding 4.61% to its value on the day. Apogee Therapeutics Inc’s shares saw a change of -11.83% in year-to-date performance and have moved 10.51% in past 5-day. Apogee Therapeutics Inc (NASDAQ:APGE) showed a performance of 12.51% in past 30-days. Number of shares sold short was 7.76 million shares which calculate 14.34 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 95 to the stock, which implies a rise of 57.96% to its current value. Analysts have been projecting 95 as a low price target for the stock while placing it at a high target of 95. It follows that stock’s current price would drop -137.86% in reaching the projected high whereas dropping to the targeted low would mean a loss of -137.86% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around -56.75% while estimates for its earnings growth in next 5 years are of -22.96%.
Apogee Therapeutics Inc (NASDAQ:APGE)’s Major holders
Insiders are in possession of 11.36% of company’s total shares while institution are holding 130.15 percent of that, with stock having share float percentage of 146.84%. Investors also watch the number of corporate investors in a company very closely, which is 130.15% institutions for Apogee Therapeutics Inc that are currently holding shares of the company. VR ADVISER, LLC is the top institutional holder at APGE for having 8.49 million shares of worth $334.21 million. And as of 2024-06-30, it was holding 15.0284 of the company’s outstanding shares.
The second largest institutional holder is RTW INVESTMENTS, LP, which was holding about 2.71 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.7989 of outstanding shares, having a total worth of $106.72 million.
On the other hand, Vanguard Specialized-Health Care Fund and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 2.0 shares of worth $79.88 million or 4.44% of the total outstanding shares. The later fund manager was in possession of 1.41 shares on Dec 31, 2024 , making its stake of worth around $56.29 million in the company or a holder of 3.13% of company’s stock.
